Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months
about
Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months
description
im April 2020 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 06 April 2020
@en
name
Immunogenicity and safety of a ...... at 2, 4, 6 and at 15-18 months
@en
type
label
Immunogenicity and safety of a ...... at 2, 4, 6 and at 15-18 months
@en
prefLabel
Immunogenicity and safety of a ...... at 2, 4, 6 and at 15-18 months
@en
P2093
P1433
P1476
Immunogenicity and safety of a ...... at 2, 4, 6 and at 15-18 months
@en
P2093
Birgit Thierry-Carstensen
Charlotte Sørensen
Henrik Wachmann
Lina Saem Stoey
Mie Vestergaard Kusk
Pernille Ingemann Nielsen
Xavier Sáez-Llorens
P356
10.1016/J.VACCINE.2020.02.066
P577
2020-04-06T00:00:00Z